July 7, 2016 09:08 AM EDTUpdated June 28, 12:29 PM

Master dealmaker? Medivation CEO David Hung’s overzealous PARP assault falls flat

Medivation doesn’t look any further ahead now that the CEO is publicly defending the asset like a dog defends a bone

Back when …

Endpoints Premium

This article is available only to Premium subscribers

Upgrade to Premium for unlimited access and Premium exclusives.

UPGRADE LOG IN

ENDPOINTS CAREERS

COO / Head of Operations (Stealth Portfolio Company)‬ ‭

Autonomy Bio Inc.

San Francisco, CA 94107, USA

view job offer post your job now

TRENDING NOW

Trump asks 'very tough hombre' Dr. Oz to lead MFN talks

About 5% of CBER and CDER left after FDA staff cuts, analysis finds

US warns drugmakers against misrepresenting cost of imported products

Merus’ Phase 2 overall survival data reach ‘home run’ scenario — analyst

Geoffrey Porges exits Schrödinger with CFO swap; A new board seat for AstraZeneca's Pascal Soriot

sponsored

Does your supply chain hold up under pressure for high-risk temperature-critical shipments?